Adaptive Biotechnologies Corporation
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
177.62 |
218.18 |
262.84 |
327.09 |
362.00 |
| Przychód Δ r/r |
0.00% |
22.84% |
20.47% |
24.45% |
10.67% |
| Przychód (min) |
174.90 |
211.55 |
243.50 |
325.61 |
346.14 |
| Przychód (max) |
179.32 |
224.63 |
279.20 |
328.58 |
376.40 |
| EBITDA (średnia) |
-164.33 |
-201.86 |
-243.18 |
-302.63 |
-334.92 |
| EBIT (średnia) |
-171.47 |
-210.64 |
-253.75 |
-315.78 |
-349.48 |
| EBIT % |
-96.54% |
-96.54% |
-96.54% |
-96.54% |
-96.54% |
| Zysk netto (średni) |
-164.02 |
-124.67 |
-97.05 |
-57.85 |
10.30 |
| Zysk netto % |
-92.34% |
-57.14% |
-36.92% |
-17.69% |
2.84% |
| EPS (średnia) |
-1.11 |
-0.85 |
-0.64 |
-0.37 |
0.07 |
| Liczba analityków (Przychody) |
7 |
6 |
8 |
4 |
2 |
| Liczba analityków (EPS) |
5 |
4 |
6 |
4 |
3 |
| symbol |
ADPT |
ADPT |
ADPT |
ADPT |
ADPT |